Type 2 Diabetes Mellitus

TITLE:
A Phase III, Randomized, Double-Blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus on Background Treatment With Glimepiride With or Without Metformin

PURPOSE:
To evaluate the safety and effectiveness of the investigational drug dutogliptin in subjects with type 2 diabetes mellitus who are also taking glimepiride alone or with metformin and who are not achieving desired blood glucose control using their regularly prescribed medications.

PHASE:
3

INSTITUTIONAL REVIEW BOARD:
Quorum
STATUS:
Closed to enrollment

ELIGIBILITY :

• People aged 18 to 85 years
• Diagnosed with type 2 diabetes for at least 3 months
• Not taking insulin or other injectable diabetic medicines
• Struggling to control blood sugar, with HbA1c >7% and <10%

DURATION:
Up to 40 weeks
PRINICIPAL INVESTIGATOR:
J. Bauman, MD

CONTACT:
Kelly Ritter, LPN, Clinical Research Coordinator
908-277-8747

For More Information:
www.DiabetesStudy.info